Mice that have been genetically engineered to lack lubricin (Prg4-/-) developed camptodactyly, synovial hyperplasia, and cartilage deterioration, similar to humans with CACP [14–16]. The gene discussed is PRG4; the disease is camptodactyly-arthropathy-coxa vara-pericarditis syndrome.